Sanara MedTech Inc (nasdaq:SMTI) Share Price

Company Profile

Business description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Contact
1200 Summit Avenue
Suite 414
Fort WorthTX76102
USA
T: +1 817 529-2300
E: [email protected]
https://www.sanaramedtech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
108

Recommended

Shares have fallen over 40% this year but revenue is still growing quickly.

Roy Van Keulen | 10 November 2026

Store closures could hit landlords.

Yingqi Tan, CFA | 09 November 2026

Short term pain, long term potential.

Esther Holloway | 09 November 2026

Index	Last price	Change	% Change
All Ordinaries	9,291.30	23.50	0.25%
CAC 40	8,306.03	27.44	0.33%
DAX 40	26,515.83	168.38	0.64%
Dow JONES (US)	52,231.89	157.86	-0.30%
FTSE 100	10,786.40	34.81	0.32%
HKSE	24,315.92	241.12	-0.98%
NASDAQ	25,065.87	187.27	-0.74%
Nikkei 225	61,248.59	789.01	1.31%
NZX 50 Index	14,179.86	12.45	0.09%
S&P 500	7,520.93	29.01	-0.38%
S&P/ASX 200	9,153.20	24.20	0.27%
SSE Composite Index	3,680.64	16.92	0.46%